Kevin W Quinlan - Net Worth and Insider Trading
Kevin W Quinlan Net Worth
The estimated net worth of Kevin W Quinlan is at least $691,356 dollars as of 2024-09-22. Kevin W Quinlan is the CFO of Anika Therapeutics Inc and owns about 27,112 shares of Anika Therapeutics Inc (ANIK) stock worth over $691,356. Details can be seen in Kevin W Quinlan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin W Quinlan has not made any transactions after 2013-03-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin W Quinlan
Kevin W Quinlan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin W Quinlan owns 2 companies in total, including Anika Therapeutics Inc (ANIK) , and Pressure BioSciences Inc (PBIO) .
Click here to see the complete history of Kevin W Quinlan’s form 4 insider trades.
Insider Ownership Summary of Kevin W Quinlan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANIK | Anika Therapeutics Inc | 2013-03-27 | Chief Financial Officer |
| PBIO | Pressure BioSciences Inc | 2005-02-11 | director & Director |
Kevin W Quinlan Latest Holdings Summary
Kevin W Quinlan currently owns a total of 1 stock. Kevin W Quinlan owns 27,112 shares of Anika Therapeutics Inc (ANIK) as of March 27, 2013, with a value of $691,356.
Latest Holdings of Kevin W Quinlan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANIK | Anika Therapeutics Inc | 2013-03-27 | 27,112 | 25.50 | 691,356 |
Holding Weightings of Kevin W Quinlan
Kevin W Quinlan Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin W Quinlan has made a total of 0 transactions in Anika Therapeutics Inc (ANIK) over the past 5 years. The most-recent trade in Anika Therapeutics Inc is the sale of 18,374 shares on March 27, 2013, which brought Kevin W Quinlan around $206,524.
Insider Trading History of Kevin W Quinlan
- 1
Kevin W Quinlan Trading Performance
GuruFocus tracks the stock performance after each of Kevin W Quinlan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin W Quinlan is 3.67%. GuruFocus also compares Kevin W Quinlan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin W Quinlan within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin W Quinlan's insider trading performs compared to the benchmark.
Performance of Kevin W Quinlan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.22 | | | | | |
| Relative Return to S&P 500(%) | -2.14 | | | | | |
Kevin W Quinlan Ownership Network
Kevin W Quinlan Owned Company Details
What does Anika Therapeutics Inc do?
Who are the key executives at Anika Therapeutics Inc?
Kevin W Quinlan is the Chief Financial Officer of Anika Therapeutics Inc. Other key executives at Anika Therapeutics Inc include SVP & Chief Operations Officer Anne Nunes , EVP & General Counsel & Corp Sec David Colleran , and EVP & CFO & Treasurer Michael L Levitz .
Anika Therapeutics Inc (ANIK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Anika Therapeutics Inc (ANIK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anika Therapeutics Inc (ANIK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Anika Therapeutics Inc (ANIK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Anika Therapeutics Inc Insider Transactions
Kevin W Quinlan Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin W Quinlan. You might contact Kevin W Quinlan via mailing address: 9 Orchard St, Marblehead Ma 01945.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
